Latest Breaking News On - Idh mutant diffuse glioma - Page 1 : comparemela.com

Vorasidenib has been granted regulatory submission acceptance by the FDA and EMA for IDH-mutant diffuse glioma.

Claude bertrandSusan pandyaEuropean commissionCancer metabolism global development oncology immunoMeeting of the society for neuroEuropean medicines agencyResearch developmentMarketing authorization applicationNew england journalCancer metabolism global development oncologyPrescription drug user fee actIdh mutant diffuse glioma